572 related articles for article (PubMed ID: 16060915)
1. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism.
Ozcan O; Cakir E; Yaman H; Akgul EO; Erturk K; Beyhan Z; Bilgi C; Erbil MK
Clin Endocrinol (Oxf); 2005 Aug; 63(2):203-6. PubMed ID: 16060915
[TBL] [Abstract][Full Text] [Related]
2. Restoration of euthyroidism does not improve cardiovascular risk factors in patients with subclinical hypothyroidism in the short term.
Beyhan Z; Ertürk K; Uçkaya G; Bolu E; Yaman H; Kutlu M
J Endocrinol Invest; 2006 Jun; 29(6):505-10. PubMed ID: 16840827
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for cardiovascular disease in women with subclinical hypothyroidism.
Luboshitzky R; Aviv A; Herer P; Lavie L
Thyroid; 2002 May; 12(5):421-5. PubMed ID: 12097204
[TBL] [Abstract][Full Text] [Related]
4. Atherogenic Lipoproteins in Subclinical Hypothyroidism and Their Relationship with Hepatic Lipase Activity: Response to Replacement Treatment with Levothyroxine.
Brenta G; Berg G; Miksztowicz V; Lopez G; Lucero D; Faingold C; Murakami M; Machima T; Nakajima K; Schreier L
Thyroid; 2016 Mar; 26(3):365-72. PubMed ID: 26839156
[TBL] [Abstract][Full Text] [Related]
5. Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism.
Arpaci D; Karakece E; Tocoglu AG; Ergenc H; Gurol G; Ciftci IH; Tamer A
Ann Clin Lab Sci; 2016 Dec; 46(6):601-607. PubMed ID: 27993872
[TBL] [Abstract][Full Text] [Related]
6. Effects of L-thyroxine treatment on early markers of atherosclerotic disease in children with subclinical hypothyroidism.
Cerbone M; Capalbo D; Wasniewska M; Alfano S; Mattace Raso G; Oliviero U; Cittadini A; De Luca F; Salerno M
Eur J Endocrinol; 2016 Jul; 175(1):11-9. PubMed ID: 27068687
[TBL] [Abstract][Full Text] [Related]
7. Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment.
Bae SW; Stühlinger MC; Yoo HS; Yu KH; Park HK; Choi BY; Lee YS; Pachinger O; Choi YH; Lee SH; Park JE
Am J Cardiol; 2005 Mar; 95(6):729-33. PubMed ID: 15757598
[TBL] [Abstract][Full Text] [Related]
8. Subclinical hypothyroidism and lipid abnormalities in older women attending a vascular disease prevention clinic: effect of thyroid replacement therapy.
Ganotakis ES; Mandalaki K; Tampakaki M; Malliaraki N; Mandalakis E; Vrentzos G; Melissas J; Castanas E
Angiology; 2003; 54(5):569-76. PubMed ID: 14565632
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Selected Atherosclerosis Risk Factors in Women with Subclinical Hypothyroidism Treated with L-Thyroxine.
Adamarczuk-Janczyszyn M; Zdrojowy-Wełna A; Rogala N; Zatońska K; Bednarek-Tupikowska G
Adv Clin Exp Med; 2016; 25(3):457-63. PubMed ID: 27629733
[TBL] [Abstract][Full Text] [Related]
10. ASYMMETRIC DIMETHYLARGININE LEVELS AND ATHEROSCLEROSIS MARKERS IN CUSHING SYNDROME.
Ozsurekci CG; Akturk M; Ozkan C; Gulbahar O; Altinova AE; Yalcin M; Arslan E; Toruner F
Endocr Pract; 2016 Sep; 22(9):1088-95. PubMed ID: 27359292
[TBL] [Abstract][Full Text] [Related]
11. Serum homocysteine, asymmetric dimethyl arginine (ADMA) and other arginine-NO pathway metabolite levels in patients with psoriasis.
Bilgiç Ö; Altınyazar HC; Baran H; Ünlü A
Arch Dermatol Res; 2015 Jul; 307(5):439-44. PubMed ID: 25708188
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients.
Hermenegildo C; Medina P; Peiró M; Segarra G; Vila JM; Ortega J; Lluch S
J Clin Endocrinol Metab; 2002 Dec; 87(12):5636-40. PubMed ID: 12466365
[TBL] [Abstract][Full Text] [Related]
14. TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).
Meier C; Staub JJ; Roth CB; Guglielmetti M; Kunz M; Miserez AR; Drewe J; Huber P; Herzog R; Müller B
J Clin Endocrinol Metab; 2001 Oct; 86(10):4860-6. PubMed ID: 11600554
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric dimethylarginine levels in thyroid diseases.
Arikan E; Karadag CH; Guldiken S
J Endocrinol Invest; 2007 Mar; 30(3):186-91. PubMed ID: 17505150
[TBL] [Abstract][Full Text] [Related]
16. Association of Subclinical Hypothyroidism with Dyslipidemia and Increased Carotid Intima-Media Thickness in Children.
Unal E; Akın A; Yıldırım R; Demir V; Yildiz İ; Haspolat YK
J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):144-149. PubMed ID: 28008862
[TBL] [Abstract][Full Text] [Related]
17. Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia.
Mao D; Che J; Li K; Han S; Yue Q; Zhu L; Zhang W; Li L
Arch Gynecol Obstet; 2010 Oct; 282(4):371-5. PubMed ID: 19806356
[TBL] [Abstract][Full Text] [Related]
18. Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction.
Wierzbicki AS; Solomon H; Lumb PJ; Lyttle K; Lambert-Hammill M; Jackson G
Atherosclerosis; 2006 Apr; 185(2):421-5. PubMed ID: 16046217
[TBL] [Abstract][Full Text] [Related]
19. The effect of L-thyroxine substitution on lipid profile, glucose homeostasis, inflammation and coagulation in patients with subclinical hypothyroidism.
Anagnostis P; Efstathiadou ZA; Slavakis A; Selalmatzidou D; Poulasouchidou M; Katergari S; Karathanasi E; Dogramatzi F; Kita M
Int J Clin Pract; 2014 Jul; 68(7):857-63. PubMed ID: 24548294
[TBL] [Abstract][Full Text] [Related]
20. Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients.
Kumagai H; Sakurai M; Takita T; Maruyama Y; Uno S; Ikegaya N; Kato A; Hishida A
Am J Kidney Dis; 2006 Nov; 48(5):797-805. PubMed ID: 17059999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
